• We found that activator drugs decrease NOsGC protein

  2022-04-02

  

  We found that activator drugs decrease NOsGC protein levels in Sf9 cells. This decrease in protein levels is more pronounced for BAY 60–2770 compared to cinaciguat, and more obvious for α1/β1 compared to α2/β1 (see Fig. 2). This led us to hypothesize that the reduction in protein level correlates wi

• cox pathway br Structural studies of GCAP Recoverin was the

  2022-04-02

  

  Structural studies of GCAP Recoverin was the first member of this subfamily of Ca2+-binding cox pathway to be investigated by structural methods [27], [54], [55], [56], [57], [58]. These proteins have four EF-hands arranged in pairs that give rise to amino- and carboxyl-terminal domains. The crys

• TMPyP4 tosylate br Materials and methods br Results br Discu

  2022-04-02

  

  Materials and methods Results Discussion Recently, we characterized the interaction of the PH domains of various Lbc family RhoGEFs with the activated small GTPase, RhoA, and demonstrated that this could serve as a positive feedback mechanism for robust activation of RhoA (Medina et al., 20

• TRAPP Transport Protein Particle complexes share a

  2022-04-02

  

  TRAPP (Transport Protein Particle) complexes share a common core architecture and function in GDC-0152 and autophagy (Kim et al., 2016). In yeast, the core complex has GEF activity for the Rab1 ortholog Ypt1. The larger TRAPPII and III complexes include regulatory subunits implicated in membrane re

• Finally our data found that the EBV dUTPase

  2022-04-02

  

  Finally, our data found that the EBV dUTPase protein modulates tryptophan, serotonin, and DA metabolism and use in vitro and in vivo. The EBV dUTPase may alter kynurenine catabolism in microglia in vitro, suggesting that there is an increase synthesis of quinolinic acid. Quinolinic acid, an agonist

• br Introduction Inflammatory bowel diseases IBDs including C

  2022-04-02

  

  Introduction Inflammatory bowel diseases (IBDs) including Crohn's disease and ulcerative colitis (Baumgart and Sandborn, 2012; Beaugerie et al., 2006) are typically characterized by chronic, progressive, and relapsing inflammation of the intestine. Although the exact pathogenesis of IBD is unknow

• Similar to GPR A activation of G protein coupled

  2022-04-02

  

  Similar to GPR109A, activation of G-protein-coupled receptor 81 (GPR81, also called HCAR1 (hydroxycarboxylic SB 204990 receptor 1)) by lactate suppresses lipolysis (Fig. 1), suggesting GPR81 to be a potential drug target for treating T2DM (Boyd et al., 1974, Cai et al., 2008, Gold et al., 1963, Hou

• A major hurdle in purifying a membrane

  2022-04-01

  

  A major hurdle in purifying a membrane protein is finding a detergent that can preserve the protein, after releasing it from a given membrane, in a stable and non-aggregated state during purification steps [18,50]. The ability of various detergents used to solubilize and purify membrane proteins has

• Ning et al showed that LPC appeared to increase insulin

  2022-04-01

  

  Ning et al. showed that LPC 18:1 appeared to increase insulin release through both GPR119-dependent and -independent mechanisms (Ning et al., 2008). In our study, we have shown that not only GPR119 but also GPR40 and GPR55 participate in LPC-stimulated insulin secretion (Fig. 4, Fig. 5) and target p

• To further implicate the role of EAAT in morphine

  2022-04-01

  

  To further implicate the role of EAAT3 in morphine-induced place preference, the effects of morphine on EAAT3 Triflusal was determined. Interestingly, morphine increased EAAT3 protein expression in the plasma membrane of mPFC, nucleus accumbens and VTA but not in the hippocampus of wild-type mice at

• Acarbose and voglibose the classic

  2022-04-01

  

  Acarbose and voglibose, the classic α-glucosidase inhibitors, were clinically used to inhibit α-glucosidase activity for the treatment of type 2 diabetes. However, the intake of these drugs may cause some undesirable gastrointestinal side effects and weight gain (Xu et al., 2015). The synthetic drug

• In conclusion we have shown

  2022-04-01

  

  In conclusion, we have shown that AKR1D1 regulates glucocorticoid availability and GR activation and therefore represents a key pre-receptor regulator of hormonal action in human liver. However, there are additional questions that need to be addressed including dissecting the broader role of AKR1D1

• br Pannexins which form channels connecting

  2022-04-01

  

  Pannexins, which form channels connecting transketolase with the extracellular environment, have also been studied in the setting of NASH. When open these channels participate in inflammatory processes. A decrease in lobular inflammation and oxidative stress was observed in mice with pannexin del

• LDC1267 receptor To date three GAL subtype receptors have be

  2022-04-01

  

  To date, three GAL subtype receptors have been cloned and characterized, GALR1, GALR2 and GALR3. However, it is unknown which one(s) of the three subtype receptors in LDC1267 receptor is most effective to regulate insulin resistance in diabetic rats as yet. Recent studies fromanimalmodels of diabet

• br Acknowledgements This work was

  2022-04-01

  

  Acknowledgements This work was supported by grants of the Argentine National Research Council (CONICET, PIP 0662). The authors express their appreciation to the Transmission Electron Microscopy Service (MET) of the Faculty of Veterinary Medicine of the National University of La Plata (Argentina)

14738 records 448/983 page Previous Next First page 上5页 446447448449450 下5页 Last page